Skip to content

Clinical trials

Phase 3 Hypogonadism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypogonadism Phase: Phase 3 Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20032
20042
20053
20063
20074
20084
20101
20125
20133
20146
20153
20162
20171
20181
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Unknown status4
Recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Repros Therapeutics Inc.8
Eli Lilly and Company3
Endo USA Inc., a Keenova Therapeutics Company3
Antares Pharma Inc.2
Ardana Bioscience Ltd2
Organon and Co2
AbbVie1
Abbott1
Amneal Pharmaceuticals, LLC1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypogonadism46
Obesity4
Eunuchism3
Prostatic Neoplasms3
Erectile Dysfunction2
Metabolic Syndrome2
Endocrine System Diseases1
Frailty1
Gonadal Disorders1
Hip Fractures1

Trials

Showing 76 to 46 of 46. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.